Skip to main content
. 2010 Sep 21;16(35):4410–4415. doi: 10.3748/wjg.v16.i35.4410

Figure 5.

Figure 5

Frequencies of serum α-fetoprotein ≥ 400 μg/L only (stripped bars), α-fetoprotein ≥ 400 μg/L and glypican-3 > 300 ng/L (filled bars) in 75 hepatocellular carcinoma patients at different Barcelona Clinic Liver Cancer stages. AFP: α-fetoprotein; GPC3: Glypican-3.